Havana, Dec 8. -A multinational research will test eight anticancer drugs created in Cuba, a researcher at Cuba's Center of Molecular Immunology (CIM) announced here.The products we use are purely national, designed from the molecule in the CIM laboratories, as well as their production in plants, Mayra Ramos, head of the CIM Clinical Trials Department, told Prensa Latina this Wednesday.
The drugs developed at the center include nimotuzumab, CimaVax-EGF, ganglioside-based vaccines, HER1vaccine and racotumobab, which are used in different treatments against lung, breast, prostate, cervix, anal and rectum cancer, said Ramos.
Another substance to be tested is Itoluzumab, which is used to treat autoimmune diseases such as rheumatoid arthritis, psoriasis and diabetes, among others.
At present, the CIM is developing 60 clinical trials, 20 of which are multinational, Ramos said during the 5th International Workshop on Design and Conducting of Clinical Trials, being held in Havana from December 5 to 7.
Professionals who work in the design and conducting of clinical trials, monitors and assistants from several countries will discuss this kind of work, ethics and the technology to support the trials. (Prensa Latina)